- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02820675
Quality Improvement in Infection COntrol and Sepsis Management in MOdel Regions (icosmos)
Quality Improvement in Infection COntrol and Sepsis Management in MOdel Regions / Deutsches Qualitaetsbuendnis Sepsis (German Quality Network Sepsis)
The German Quality Network Sepsis is an association trying to improve quality of care for patients with sepsis, severe sepsis and septic shock or being in risc thereof.
The icosmos trial investigates the impact on the use of routine data, a risk adjustment algorithm and feedback to all hospitals as well as a structured implementation for regular screening for deteriorating patients, and education on in-hospital mortality.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
All German hospitals provide a set of routine data to federal adminsitration for reimbursement. This dataset includes all ICD-10-Codes (German adaption) as well as all procedure codes.
This dataset is pseudonomized and risk adjusted for every individual case and afterwards feedbacked to each participating hospital including all accumulated data from all other hospitals as well as the German Average for sepsis mortalities provided by the German Federal Institute of Statistcs for benchmarkings.
Based on this data, the icosmos trial will provide support to all participating hospitals for two major strategies to be implemented
An algorithm for structured analysis of
- low-risk-fatalities as potentially preventable deaths for underlying problems in diagnosis, treatment, etc
- high-risk-survivors as "best practice"
- coding errors for improvement of coding quality
- a structured sreening program of every patient on every ward in every shift for deterioration and support algorithms including consiliary support and outreach teams as well as structured education
The icosmos trial will investigate the effects as well on quality of coding and sepsis incidence as well as on sepsis-related sepsis in-hospital mortality for participating hospitals in comparison to the German Average.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Thuringia
-
Jena, Thuringia, Germany, 07747
- CSCCGermany
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria for hospitals:
- hospitals willing to participate
Inclusion Criteria for patients / patients' data
- age over 16
- coding of sepsis, severe sepsis, septic shock
Exclusion Criteria for hospitals:
- no intensive care unit on site
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: intervention
all hospitals participating in the icosmos trial will be supported in implenatation of the two main interventions.
|
implementation of a structured analysis of cases coded as sepsis, severe sepsis, or septic shock after risk adjustment for low-risk-fatalities, high-risk-survivors, and coding errors for preventable deaths, best practice, quality improvement and improvement in coding precision.
implementation of a strutured screening and rescue algorithm on regular wards, emergency departements, and intermediate and intensive care units by checking every patient in every shifts for clinical signs of deterioration and apllying a rescue algorithm including consiliary help and/or the help of outreach teams
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
in-hospital mortality
Time Frame: 3 years
|
in-hospital mortality of all patients coded with sepsis, severe sepsis and septic shock in absolute numbers and in relation to the German average
|
3 years
|
sepsis codings
Time Frame: 3 years
|
developement of coding of sepsis, severe sepsis and septic shock in absolte numbers and in relation to the German Average
|
3 years
|
Collaborators and Investigators
Collaborators
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CSCCGermany
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sepsis
-
University of Kansas Medical CenterUniversity of KansasRecruitingSepsis | Septic Shock | Sepsis Syndrome | Sepsis, Severe | Sepsis Bacterial | Sepsis BacteremiaUnited States
-
Jip GroenInBiomeRecruitingMicrobial Colonization | Neonatal Infection | Neonatal Sepsis, Early-Onset | Microbial Disease | Clinical Sepsis | Culture Negative Neonatal Sepsis | Neonatal Sepsis, Late-Onset | Culture Positive Neonatal SepsisNetherlands
-
The University of QueenslandRoyal Brisbane and Women's HospitalUnknown
-
Karolinska InstitutetÖrebro University, SwedenCompletedSepsis | Sepsis Syndrome | Sepsis, SevereSweden
-
Ohio State UniversityCompletedSepsis, Severe Sepsis and Septic ShockUnited States
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
University of LeicesterUniversity Hospitals, Leicester; The Royal College of AnaesthetistsCompletedSepsis | Septic Shock | Severe Sepsis | Sepsis SyndromeUnited Kingdom
-
Beckman Coulter, Inc.Biomedical Advanced Research and Development AuthorityRecruitingSevere Sepsis | Severe Sepsis Without Septic ShockUnited States
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI); New York Presbyterian Hospital and other collaboratorsCompletedSepsis | Septic Shock | Severe Sepsis | Infection | Sepsis SyndromeUnited States
-
Inverness Medical InnovationsCompletedSepsis | Systemic Inflammatory Response Syndrome | Severe Sepsis | Sepsis SyndromeUnited States
Clinical Trials on structured case analysis
-
Karolinska University HospitalEnrolling by invitationAneurysm | Aortic Aneurysm | Abdominal Aortic Aneurysm, Ruptured | Aneurysm Abdominal | Abdominal Aortic Aneurysm Without RuptureSweden
-
University of MilanUniversity of Pavia; IRCCS Policlinico S. Matteo; Humanitas Hospital, Italy; Papa... and other collaboratorsCompleted
-
AZ Sint-Jan AVCompletedAtrial Fibrillation | Atrial TachycardiaFrance, Belgium, Germany, United Kingdom
-
Azienda Unità Sanitaria Locale Reggio EmiliaRecruitingService EvaluationItaly
-
National Taiwan University HospitalCompleted
-
University of Wisconsin, MadisonNational Institute on Aging (NIA); Oregon Health and Science University; University...Completed
-
Harvard University Faculty of MedicineCompletedProblem-based Learning | Education, Medical | Problem Solving | Education, Medical, Undergraduate | Interactive TutorialUnited States
-
Christian SchweglerRecruitingChemotherapy Effect | Breast Cancer FemaleSwitzerland
-
Istanbul UniversityMedipol University; Istanbul University - Cerrahpasa (IUC)Completed
-
University of Wisconsin, MadisonUniversity of Alabama at Birmingham; National Institute on Aging (NIA); University... and other collaboratorsEnrolling by invitationCommunication | Serious InjuryUnited States